THE AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATION

The Amyotrophic Lateral Sclerosis Association specializes in public health communications, patient outreach, and registry support services for neurodegenerative disease initiatives. Their core capabilities center on designing and executing national awareness campaigns, managing stakeholder engagement platforms, and delivering targeted public health messaging to patients, caregivers, and medical professionals. They bring deep expertise in health education strategy, data-driven outreach programs, and community-based dissemination of clinical research findings, with a focused specialization in amyotrophic lateral sclerosis (ALS) advocacy and registry operations. Their work integrates health informatics, behavioral communication models, and multi-channel engagement frameworks to enhance public understanding and participation in federally funded disease surveillance efforts. The organization maintains a consistent relationship with the Department of Health and Human Services, delivering mission-critical communications and outreach services aligned with public health surveillance and patient registry objectives. Their engagements with HHS are characterized by long-term, mission-aligned partnerships focused on sustaining national ALS data collection systems and expanding access to clinical resources through targeted public education. Their primary industry focus is within voluntary health organizations (NAICS 813212) and professional, scientific, and technical services (NAICS 541990), where they function as a mission-driven contractor supporting federal public health infrastructure. They position themselves as a niche provider in neurological disease advocacy, bridging nonprofit advocacy with federal research and data management priorities. As a nonprofit entity structured under 8H, the organization operates from Arlington, Virginia, with no formal government certifications. Their market presence is defined by specialized expertise in ALS-focused public health initiatives rather than broad-scale federal contracting capacity, making them a unique partner for HHS programs requiring deep disease-specific knowledge and community trust.